Rising allegations of asbestos-contaminated talc in varied shopper merchandise, coupled with historic approval of a brand new remedy for pleural mesothelioma, made 2020 a yr full of each nervousness and hope.
Johnson & Johnson stopped promoting its iconic child powder in Could after being hit by 1000’s of lawsuits contending its talc-based product was inflicting varied cancers, together with ovarian most cancers and malignant mesothelioma.
The U.S. Meals and Drug Administration accepted the immunotherapy mixture of Opdivo and Yervoy in October, the primary new drug routine accepted for first-line treatment of unresectable illness in 16 years.
There additionally have been inspiring mesothelioma survivors who emerged, promising scientific trials that opened and tireless most cancers specialists breaking new floor all through the previous 12 months.
Listed here are the ten most-circulated mesothelioma and asbestos-related information tales in 2020.
Johnson & Johnson Drops Talc-Primarily based Child Powder
Swayed by an avalanche of lawsuits alleging asbestos contamination and a most cancers threat in its product, Johnson & Johnson introduced in Could it might cease promoting its talc-based Johnson’s Child Powder in the US and Canada.
The corporate had been manufacturing the product for greater than 100 years.
It remained steadfast in its insistence that its child powder was secure to make use of, attributing the halt in distribution to a decline in shopper demand, litigation promoting and “misinformation” in regards to the security.
Talc-based Johnson’s Child Powder will proceed to be offered outdoors North America. A cornstarch model will turn out to be the usual inside the U.S. and Canada.
Johnson & Johnson Pays $100 million to Settle Lawsuits
Johnson & Johnson remained within the information when it agreed to pay $100 million to settle greater than a thousand lawsuits claiming its talc-based child powder precipitated most cancers.
Though it had settled a small variety of particular person claims both earlier than or throughout trials previously, this was the primary time it had settled lawsuits in bulk over its controversial child powder.
Regardless of the settlement in October, J&J continued to insist its product was secure and that any asbestos contamination present in testing was an remoted occasion.
Nearly all of the instances contain girls who used the product for a few years and developed ovarian most cancers. Solely a small proportion have been associated to mesothelioma, a extra aggressive most cancers precipitated nearly completely by exposure to asbestos.
Revlon Turns into Newest Talc Lawsuit Goal
Revlon turned the most recent beauty firm to be sued for alleged asbestos-contaminated talc in one in every of its merchandise that precipitated mesothelioma most cancers.
A Maryland couple filed the lawsuit in New York state court docket, in search of $20 million in compensatory damages and $40 million in punitive damages.
The girl believes her mesothelioma stems from her father’s earlier employment with Revlon and the merchandise he supplied her. Jean Naté Silkening Physique Powder was one in every of them and is not manufactured.
Many beauty merchandise include talc, which is likely one of the world’s softest minerals. It’s mined close to the Earth’s service. Sadly, it’s usually discovered close to deposits of asbestos.
Revlon joined Justice, one other retailer advertising cosmetics to younger women, as a lawsuit goal. Beauty firms, although, have been defendants in solely a small fraction of talc instances.
Asbestos Present in Eyeshadow
Asbestos-contaminated talc was present in two new eyeshadow merchandise. Each have been offered primarily on-line by web sites eBay and Amazon.
Asbestos fibers have been present in 40% of shades from Jmkcoz 120 Colours Eyeshadow Palette and 20% of shades from Magnificence Glazed Attractive Me Eye Shadow Tray Palette samples.
Testing was achieved by Scientific Analytical Institute in Greensboro, North Carolina, which makes use of transmission electron microscopy. The discovering got here within the wake of one other research achieved by the FDA that discovered contaminated talc in 9 of 52 beauty merchandise examined.
Keytruda Accredited for Choose Most cancers Sufferers
The U.S. FDA accepted the immunotherapy drug pembrolizumab in June for sure metastatic tumors, together with a small quantity involving pleural mesothelioma.
The drug, additionally recognized by the model title Keytruda, was accepted for unresectable illness and excessive mutational burden that has progressed after first-line remedy with no different choices remaining.
In earlier scientific trials involving mesothelioma sufferers, Keytruda had been particularly efficient, however solely with a small proportion of sufferers.
“It may be used for mesothelioma, but it surely’s not the magic bullet,” Dr. Raja Flores, specialist at Mount Sinai Hospital in New York, advised The Mesothelioma Middle at Asbestos.com. “Its general effectiveness is modest at greatest.”
Missouri Upholds Landmark Johnson & Johnson Verdict
A Missouri Courtroom of Appeals upheld a landmark jury verdict in opposition to Johnson & Johnson, however lowered a record-setting award for punitive and compensatory damages from $4.69 billion to $2.1 billion in June.
The case concerned 22 girls alleging their ovarian most cancers had been brought on by Johnson & Johnson’s asbestos-contaminated talc merchandise.
The corporate stated it might attraction once more with the Missouri Supreme Courtroom, however the court docket refused to listen to the case. J&J has been overwhelmed by greater than 19,000 lawsuits in federal and U.S. state courts involving its talc merchandise.
FDA Finds Damaging Proof of Asbestos in Make-up
In probably the most incriminating research up to now, the U.S. Meals and Drug Administration discovered asbestos-contaminated talc in 9 of the 52 beauty merchandise it examined throughout a year-long research.
Claire’s, Metropolis Shade and Johnson & Johnson have been among the many manufacturers wherein asbestos was discovered.
The research accentuated the continuing dispute over testing strategies and the precise quantification of asbestos minerals. Transmission electron microscopy discovered asbestos in all 9 merchandise. Polarized mild microscopy discovered asbestos in solely two of the 52.
Standardized Talc Testing Features Traction
Specialists from eight completely different federal businesses have beneficial using standardized testing of beauty talc for the presence of asbestos and different probably dangerous mineral merchandise.
The suggestions are designed to finish the continuing evaluation discrepancies of whether or not merchandise are contaminated with cancer-causing substances.
These testing suggestions have been a part of a broader research designed to enhance shopper product security and introduced to the U.S. Meals and Drug Administration.
Asbestos Ban Takes A long time to Present Advantages
Virtually 30 years after banning asbestos, the nation of Italy is simply now seeing the height of its mesothelioma most cancers disaster.
Italy has served for instance of why the medical subject ought to proceed its work towards discovering a mesothelioma cure, even with tighter rules and a possible ban looming in different international locations.
Analysis has proven there isn’t a quick profit from an asbestos ban. A analysis of mesothelioma – precipitated nearly completely by asbestos – can take as much as 50 years after publicity.
FDA Approves Immunotherapy for Mesothelioma
Elevating hopes for sufferers and households all through the nation, the U.S. Meals and Drug Administration accepted its first new drug remedy routine in 16 years for malignant pleural mesothelioma most cancers.
In October, the FDA accepted the immunotherapy mixture of Opdivo and Yervoy for first-line remedy of unresectable illness.
The approval stemmed from a world section III scientific trial wherein the mixture demonstrated superior general survival when in comparison with commonplace chemotherapy.
This milestone was most dramatic for these with the sarcomatoid or biphasic mesothelioma cell type. Median general survival went from 8.8 months with chemotherapy to 18.1 months with the immunotherapy mixture.
Get Entry to Free Sources for Sufferers & Liked Ones